ESR2 and breast cancer: The prognostic influence of ERβ in TNBC is also disputable, with some studies suggesting that ERβ possesses anti-proliferative and -invasive functions in breast cancer cells, possibly by suppressing the PI3K/Akt/mTOR signaling pathway (Lei et al., 2020).